Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

PsiOxus Therapeutics Elects Paolo Paoletti as Chairman of the Board

PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman. “I am certain that Paoletti’s proven experience in oncology drug … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Idera Pharmaceuticals Elects Maxine Gowen to Board of Directors

Idera Pharmaceuticals, a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, has appointed Maxine Gowen to its board of directors. “Gowen brings a wealth of industry knowledge and experience along with organization … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

F-star Deepens Scientific Leadership with CSO Hire

F-star, a biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology, has appointed of Dr Neil Brewis as Chief Scientific Officer. Dr Brewis joins F-star from GlaxoSmithKline (GSK) where as Vice President, Head of Biopharmaceutical Research he led a global … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

VCs Listening to Pitches for Age-related Diseases

Author: Karl Simpson Age related diseases are strongly featuring in investor’s minds these days, and UK start-up Autifony, focused on age-related hearing loss and which spun out of GSK in 2013, just banked a further £8m as an extension to … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , | Leave a comment

Prosensa announces senior management and board appointments

Authored by Karl Simpson Prosensa HoldingsN.V, the drug development company focused on advancing therapies for duchenne muscular dystrophy announced the appointment of Willem W. van Weperen to the new position of chief commercial officer and the addition of Dr. Annalisa Jenkins … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Recruitment Market | Tagged , , , , , , , , , , , , | Leave a comment

Gene Therapy Start-up AAVLife raises $12m

Authored by James Sheppard The Paris based biotechnology company, AAVLife announced that it had raised $12m in series A funding for its gene therapy assets. The funding round, led by Versant Ventures, will be used to advance a gene-deleting therapy … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

PTC Therapeutics appoints Chief Medical Officer and communicates CHMP conditional decision

Authored by Karl Simpson For patients living with Duchenne Muscular Dystrophy, last year offered great hope but also disappointment. The momentum was building in the development of exciting new therapies and they were looking forward to the promise of meaningful … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Academic and industry partnerships drive new Gene Therapy push

Authored by James Sheppard There are many areas of pharmaceutical innovation currently receiving considerable attention, both for their scientific potential in a personalised medicine era but equally because of the potential they offer to investors. Gene Therapy is one such … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

AnaptysBio expands its cancer immunotherapy portfolio

Authored by Karl Simpson Anti-PD1 Antibody combined with TIM-3 and LAG-3 antagonists  Cancer Immunotherapy is an area that is gaining increasing levels of interest across the cancer therapeutics markets and in the life sciences market in general. This year, new … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Isis gains milestone from GSK for rare disease trial and Aegerion takes them on in HoFH

Authored by Karl Simpson Isis Pharmaceuticals is developing a drug for the treatment of the rare diseases transthyretin amyloidosis. The disease is a severe and rare genetic disorder characterized by dysfunction of the peripheral nerve and/or heart tissues. The company … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap